ClinicalTrials.Veeva

Menu

The Effect of 360 Video and MAPS on Enrollment in the DPP

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Completed

Conditions

Diabetes Mellitus, Type 2
PreDiabetes

Treatments

Behavioral: Mobile 360° Video intervention
Behavioral: Motivation and Problem Solving (MAPS)
Behavioral: Risk notification/education

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT04746781
00132307

Details and patient eligibility

About

We will conduct a three-armed randomized, clinical trial to test the incremental effectiveness of Mobile 360° Video and Motivation and Problem Solving in motivating individuals with Prediabetes to enroll in the Diabetes Prevention Program. all participants will receive notification that they have Prediabetes and education about Prediabetes, Type 2 diabetes, and the Diabetes Prevention Program, some participants will receive the additional interventions

Full description

More than 88 million Americans are at risk of developing Type 2 diabetes mellitus (T2DM). The one-year Diabetes Prevention Program (DPP) has been shown to be effective in reducing the risk of progressing from prediabetes to T2DM. However, most individuals who could benefit from the program never enroll.

Prior research has elucidated several reasons people do not enroll in the DPP. First, many people are not aware that they are at risk of developing T2DM, or that an efficacious program like the DPP exists. Second, the complications from T2DM are abstract, distal and difficult to imagine, which in turn leads to low motivation for risk-reducing behaviors. Finally, practical barriers limit DPP enrollment including cost, travel time, and scheduling. Prior research has tested rational appeals (such as provider-based education and referral) to enroll individuals in the DPP, with limited efficacy. In this project we will compare the effects of notification and education alone, notification and education plus mobile phone delivered videos (emotional appeal), and notification and education plus phone-based coaching utilizing a motivation and problem-solving approach. Our primary outcome will be enrollment and 1-month engagement in the DPP.

This three-armed randomized, clinical trial will be conducted within 2 health systems. Following an opt-out procedure offered to all eligible participants, participants will complete informed consent and a baseline survey. In the risk notification/education arm, we will send all participants a short message service (SMS) message with a link to a website that educates the public about their risk for developing T2DM and about the availability and efficacy of the DPP to address their risk. In the Mobile 360° Video intervention arm, after risk notification/education, participants will receive links to two 3-minute immersive Mobile 360° Videos (in which the viewer moves their phone to 'look around' the world of the video) on their smart phones. These videos are intended to influence affective and experiential perceptions of risk. The first video tells an emotional story of the negative effects on an individual's health and family life as they progress from prediabetes to T2DM and develop cardiovascular complications. The second video provides the viewer with a vicarious experience of the changes in vision that occur as diabetic retinopathy develops and worsens.

In the Motivation and Problem Solving (MAPS) arm, after risk notification/education, participants will be called by a health coach trained in counseling/coaching. The coach will guide them in setting health related goals and addressing any practical barriers to enrolling/engaging in the DPP, if that is consistent with their health goals.

Enrollment

818 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Are aged 18-89
  • Have a diagnosis of prediabetes within the past 5 years (ICD-10 code R73.03)
  • Have an email and mobile telephone number on record with the Health-system
  • Primary language of either English or Spanish

Exclusion criteria

  • Type 2 diabetes mellitus (ICD-10-CM E11);
  • Type 1 diabetes mellitus (ICD-10-CM Diagnosis E10),
  • Diabetes mellitus due to underlying condition (ICD-10 E08);
  • Drug or chemical induced diabetes mellitus (ICD-10 E09);
  • Gestational diabetes (ICD-10 024.4);
  • Neonatal diabetes mellitus (ICD-10 P70.2);
  • Post-pancreatectomy diabetes mellitus (ICD-10 E13).
  • Patients whose primary language is other than Spanish or English will be excluded.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

818 participants in 3 patient groups

Risk notification/education arm
Active Comparator group
Description:
We will send all participants a short message service (SMS) message with a link to a website that educates the public about their risk for developing T2DM and about the availability and efficacy of the DPP to address their risk
Treatment:
Behavioral: Risk notification/education
Mobile 360° Video intervention arm
Experimental group
Description:
After risk notification and education, participants will receive links to two 3-minute immersive Mobile 360° Videos (in which the viewer moves their phone to 'look around' the world of the video) on their smart phones. These videos are intended to influence affective and experiential perceptions of risk. The first video tells an emotional story of the negative effects on an individual's health and family life as they progress from prediabetes to T2DM and develop cardiovascular complications. The second video provides the viewer with a vicarious experience of the changes in vision that occur as diabetic retinopathy develops and worsens.
Treatment:
Behavioral: Risk notification/education
Behavioral: Mobile 360° Video intervention
Motivation and Problem Solving (MAPS) arm
Experimental group
Description:
After risk notification and education, participants will be called by a health coach trained in counseling/coaching. The coach will guide them in setting goals related to their health, and addressing any practical barriers to enrolling/engaging in the DPP if that is consistent with their health goals. Per their preference, participants will receive up to 5 phone calls from the health coach over a 4 week period.
Treatment:
Behavioral: Risk notification/education
Behavioral: Motivation and Problem Solving (MAPS)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems